In April 2024, the U.S. Food and Drug Administration approved a brand-new antibiotic called pivmecillinam (Pivya) for the treatment of uncomplicated urinary tract infections (UTIs) in adult women (FDA News Release, April 2024, https://bit.ly/4dnC5DI...